Reneo Net Tangible Assets from 2010 to 2024
| RPHM Stock | USD 1.70 0.04 2.30% |
Net Tangible Assets | First Reported 2010-12-31 | Previous Quarter 115 M | Current Value 120.7 M | Quarterly Volatility 67.4 M |
Check Reneo Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Reneo Pharmaceuticals' main balance sheet or income statement drivers, such as Net Interest Income of 24.8 K, Interest Income of 24.8 K or Depreciation And Amortization of 551.2 K, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.58. Reneo financial statements analysis is a perfect complement when working with Reneo Pharmaceuticals Valuation or Volatility modules.
Reneo | Net Tangible Assets |
Latest Reneo Pharmaceuticals' Net Tangible Assets Growth Pattern
Below is the plot of the Net Tangible Assets of Reneo Pharmaceuticals over the last few years. It is the total assets of a company minus any intangible assets such as patents, copyrights, and goodwill; it represents the physical assets of a company. Reneo Pharmaceuticals' Net Tangible Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Reneo Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
| Net Tangible Assets | 10 Years Trend |
|
Net Tangible Assets |
| Timeline |
Reneo Net Tangible Assets Regression Statistics
| Arithmetic Mean | 13,965,018 | |
| Coefficient Of Variation | 482.83 | |
| Mean Deviation | 56,933,360 | |
| Median | (23,127,000) | |
| Standard Deviation | 67,427,681 | |
| Sample Variance | 4546.5T | |
| Range | 189.3M | |
| R-Value | 0.73 | |
| Mean Square Error | 2298T | |
| R-Squared | 0.53 | |
| Significance | 0 | |
| Slope | 10,983,262 | |
| Total Sum of Squares | 63650.9T |
Reneo Net Tangible Assets History
About Reneo Pharmaceuticals Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Reneo Pharmaceuticals income statement, its balance sheet, and the statement of cash flows. Reneo Pharmaceuticals investors use historical funamental indicators, such as Reneo Pharmaceuticals's Net Tangible Assets, to determine how well the company is positioned to perform in the future. Although Reneo Pharmaceuticals investors may use each financial statement separately, they are all related. The changes in Reneo Pharmaceuticals's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Reneo Pharmaceuticals's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Reneo Pharmaceuticals Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Reneo Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Tangible Assets | 115 M | 120.7 M |
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Reneo Pharmaceuticals using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Additional Information and Resources on Investing in Reneo Stock
When determining whether Reneo Pharmaceuticals is a strong investment it is important to analyze Reneo Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Reneo Pharmaceuticals' future performance. For an informed investment choice regarding Reneo Stock, refer to the following important reports:Check out the analysis of Reneo Pharmaceuticals Correlation against competitors. To learn how to invest in Reneo Stock, please use our How to Invest in Reneo Pharmaceuticals guide.You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Reneo Pharmaceuticals. If investors know Reneo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Reneo Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.17) | Return On Assets (0.52) | Return On Equity (0.84) |
The market value of Reneo Pharmaceuticals is measured differently than its book value, which is the value of Reneo that is recorded on the company's balance sheet. Investors also form their own opinion of Reneo Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Reneo Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Reneo Pharmaceuticals' market value can be influenced by many factors that don't directly affect Reneo Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Reneo Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Reneo Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Reneo Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.